Gates, No­vo Nordisk, Well­come foun­da­tions put $300M in glob­al health; BioN­Tech stops prostate can­cer study

Plus, news about Eye­Point, Lyra Ther­a­peu­tics and Plus Ther­a­peu­tics:

For glob­al health, $300 mil­lion: The Bill & Melin­da Gates Foun­da­tion, the No­vo Nordisk Foun­da­tion and Well­come are each pitch­ing in $100 mil­lion to fund re­searchers work­ing on im­prov­ing health in low- and mid­dle-in­come coun­tries. The group will fo­cus on three ar­eas: con­nec­tions be­tween cli­mate change and health; an­timi­cro­bial re­sis­tance, in­fec­tious dis­ease sur­veil­lance and vac­cine de­vel­op­ment; and study­ing the in­ter­play be­tween nu­tri­tion, im­mu­ni­ty, in­fec­tious dis­eases and car­diometa­bol­ic dis­ease. — Ryan Cross

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER